Form D Explorer

Form C — Deverra Therapeutics, Inc.

0001665160-24-000283 · filed 2024-03-28 · via StartEngine Capital, LLC

Offering

Target: $14,999
Maximum: $1,234,999
Security type: Common Stock
Price per security: $2.0900
Deadline: —
Oversubscription: Accepted

Issuer

Name: Deverra Therapeutics, Inc.
CIK: 1822782
Entity: Corporation
Jurisdiction: DE
Address: 1600 Fairview Ave E STE 300
Seattle, WA 98102
Phone: —

Most recent fiscal year financials

Total assets

$327,030

Cash

—

Short-term debt

$7,448,108

Long-term debt

$256,667

Revenues

—

COGS

$6,678,838

Taxes paid

—

Net income

$-6,899,704

View original on SEC EDGAR.